Pageviews past week

Monday, June 12, 2017

A bit lower today as the Dow fell 36 points on pretty good volume.  The advance/declines were slightly positive.  The summation index is trying to go up but is basically moving sideways.  We did come up from the lows of the session and that's a positive.  However the small stocks are relative under performers here and that isn't a good sign.  I did place an order for the SPY June calls but it wasn't filled.  I would like to attempt this trade at some point in the next two trading days.  I do believe that we'll see strength towards the latter half of the week.  The entry will have to be spot on since there is such little time remaining in the June option cycle.  We do have the Fed to contend with on Wednesday.  GE suddenly came to life today and jumped a buck on extremely heavy volume.  The double bottom with the RSI positive divergence actually ended up working out.  GE announced a new CEO today and that was the reason for the jump.  Gold lost a couple of bucks on the futures as the US dollar was little changed.  The XAU lost almost a buck and GDX almost a dime on light volume.  I'm still considering a longer term option trade for the gold shares.  Mentally I'm feeling OK.  We got another pop in the VIX today but it is not completely overbought just yet.  One more sell off should do it but when that will happen is the question.  Once again, with only four days to go in the June option cycle the risk is very high.  I'm hoping that I'm up to the task.  With a Fed announcement thrown in there as well, you can see how difficult things can become.  I might have to wait until after the Fed meeting to put on this trade but we'll have to see how things move before that event.  I do think that the SPY June calls are the way to go here and I do think that there will be some money to be made.  We'll see.  Europe and Asia were both lower overnight as the worldwide markets are taking a breather as well.  We'll keep an eye on the overnight developments.

1 comment:

pranjali upadhyay said...

Sun Pharma surges on getting USFDA nod for Zetia generic
Capitalstars